Cochrane Abstracts
Intravenous immunoglobulin for the treatment of Kawasaki disease in children Stable (no update expected for reasons given in 'What's new')
Intravenous immunoglobulin for the treatment of Kawasaki disease in children Stable (no update expected for reasons given in 'What's new') is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Intravenous Immunoglobulin for the Treatment of Kawasaki Disease in Children Stable (no Update Expected for Reasons Given in 'What's New')." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432634/all/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed 28 January 2022.
Intravenous immunoglobulin for the treatment of Kawasaki disease in children Stable (no update expected for reasons given in 'What's new'). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432634/all/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed January 28, 2022.
Intravenous immunoglobulin for the treatment of Kawasaki disease in children Stable (no update expected for reasons given in 'What's new'). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432634/all/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease in Children Stable (no Update Expected for Reasons Given in 'What's New') [Internet]. In: Cochrane Abstracts. [cited 2022 January 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432634/all/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children_Stable__no_update_expected_for_reasons_given_in_'What's_new'_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous immunoglobulin for the treatment of Kawasaki disease in children Stable (no update expected for reasons given in 'What's new')
ID - 432634
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432634/all/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
DB - Evidence Central
DP - Unbound Medicine
ER -
